Opendata, web and dolomites

PREKIND

PreEclampsia diagnosis by Early Kidney Injury Detection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PREKIND project word cloud

Explore the words cloud of the PREKIND project. It provides you a very rough idea of what is the project "PREKIND" about.

urine    millions    assays    exceptional    syndrome    http    months    renal    claims    pregnancy    licensed    specificity    vesna    babies    accounts    ib    annually    too    life    complications    damage    cardiovascular    75    innovative    podocyte    budgets    tests    flow    develops    feasibility    pe    podocin    business    31billion    health    pioneering    predict    org    prognostic    solutions    000    biomarker    women    rest    worldwide    500    estimates    preeclampsia    ambition    mayo    introduction    demonstrated    preelampsia    dr    spend    diagnostic    biomarkers    alone    ruo    sensitivity    contribution    sub    care    diagnose    7billion    annual    pregnant    year1    diagnosis    risk    surviving    informbio    foundation    survive    plan    deaths    conduct    variety    direct    infant    clinical    cytometry    indicate    form    world    provision    antenatal    ongoing    dealing    lives    elisa    emerge3    innovation    clinic    symptoms    leader    usa    garovic    disease    mothers   

Project "PREKIND" data sheet

The following table provides information about the project.

Coordinator
INFORM BIOSCIENCE LIMITED 

Organization address
address: HOFFMAN PARK LITTLE ISLAND COUNTY CORK
city: CORK
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website http://www.informbio.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2015-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INFORM BIOSCIENCE LIMITED IE (CORK) coordinator 50˙000.00

Map

 Project objective

Health Challenge: PreEclampsia (PE) claims the lives of 75,000 women annually and the 6,000,000 surviving mothers will have an increased risk of cardiovascular disease for the rest of their life. PE accounts for over 500,000 infant deaths worldwide every year1; and for the millions of babies that survive, they too will go on to have increased risk of a variety of health issues. PE is a syndrome that develops during pregnancy but presents no clinical symptoms during most of the pregnancy and is therefore currently complex to diagnose. Business Challenge: With an annual spend of over 31Billion in direct costs in the developed world alone, the provision of antenatal care to pregnant women has a significant impact on health care budgets; dealing with the immediate consequences of PE form an important contribution to this cost. The Preelampsia foundation (http://www.preeclampsia.org/) estimates the annual cost of PE is more than $7billion in the US. InformBio Business Innovation: InformBio (IB) has licensed pioneering research by Dr.Vesna Garovic of the Mayo Clinic, USA. The technology has identified podocyte specific biomarkers in urine that indicate ongoing renal damage and which allow for a sub-clinical diagnosis for PE. The key biomarker, podocin, has demonstrated exceptional sensitivity and specificity and can diagnose the disease up to 3 months before clinical symptoms emerge3. InformBio are currently working to develop flow cytometry and research use only (RUO) ELISA assays for the biomarker. InformBio’s ambition is to be the world leader in early pregnancy prognostic tests, offering the most innovative, cost effective solutions to predict pregnancy complications.

Phase 1 proposal: To conduct a feasibility study to support the development of a detailed business plan for the introduction of a PE diagnostic test.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREKIND" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREKIND" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More